Generic Sweden ABOMXSTO: GENI

GENI: SaaS-driven margin growth and strong DOCS adoption boost results amid CEO transition

· Issued by Generic Sweden AB

Revenue rose 6% and EBITDA surged 39% year-over-year, driven by SaaS growth and margin expansion, while healthcare and e-health segments outperformed logistics and e-commerce. CEO transition and strong DOCS adoption mark key developments.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

Generic Sweden AB on 6ix

Earlier from Generic Sweden

Later from Generic Sweden

All Generic Sweden news releases